Stanford Experts Warn Older Adults of 5 Hidden Cannabis Risks
Cannabis use is surging among adults over 65, but Stanford Medicine specialists say today's potent marijuana carries serious, underestimated health risks.
Summary
Cannabis use among Americans over 65 is climbing fast, with 7% reporting recent use in 2023. Stanford Medicine experts are raising alarms because today's cannabis is dramatically stronger than older adults may remember — modern flower averages 20% THC versus 1-4% in the 1970s. Specialists identify five key risks for older users: cardiovascular problems, falls and accidents, memory and cognitive impairment, dangerous interactions with common medications, and addiction potential. Many seniors use cannabis hoping to ease pain, insomnia, or anxiety, but experts say there is no broad medical consensus supporting its effectiveness for these conditions. The combination of higher potency products, age-related physiological changes, and polypharmacy makes this population especially vulnerable to serious adverse effects.
Detailed Summary
Cannabis use among adults over 65 is rising rapidly across the United States, and Stanford Medicine specialists are sounding the alarm about risks that are growing alongside its popularity. While many older adults turn to cannabis seeking relief from chronic pain, insomnia, or anxiety, experts warn that the drug's risks in this demographic are significantly underestimated and understudied.
The most striking concern is potency. Marijuana in the 1970s contained just 1–4% THC, the psychoactive compound. Today's legal cannabis flower averages around 20% THC, with some strains reaching 35%. Oils, edibles, and concentrates can approach 90% THC. This dramatic increase means older adults experimenting with cannabis based on past experience may severely misjudge appropriate dosing, raising the risk of accidental overuse.
Stanford's geriatric and psychiatric specialists outline five primary risks for users over 65: heart problems including arrhythmias and increased cardiovascular strain; fall risk due to impaired balance and cognition; memory and cognitive decline, particularly with regular high-THC use; dangerous drug interactions, as cannabis can interfere with blood thinners, heart medications, and other common prescriptions; and addiction, which is a clinically recognized risk even in older populations.
A complicating factor is that federal illegality has hampered rigorous large-scale research, leaving major gaps in understanding how cannabis affects the aging body and brain over time. Despite limited evidence, use continues to grow, often without physician guidance. Geriatric nurse practitioner Eloise Theisen notes that many older patients use cannabis regardless of provider approval, making informed clinical conversations essential.
For health-conscious older adults, the practical takeaway is clear: approach cannabis with the same caution as any potent pharmaceutical. Disclose use to all healthcare providers, start at very low doses, avoid high-concentration products, and be especially vigilant about interactions with existing medications.
Key Findings
- Modern cannabis averages 20% THC — up to 20x stronger than 1970s marijuana, dramatically increasing overdose and adverse event risk.
- Adults over 65 face heightened risks of heart problems, falls, cognitive decline, addiction, and dangerous drug interactions from cannabis use.
- 7% of adults over 65 reported recent cannabis use in 2023, up from under 5% in 2021, with use accelerating.
- No broad medical consensus supports cannabis as an effective treatment for pain, insomnia, or anxiety in older adults.
- Many older adults use cannabis without physician guidance, creating unmanaged risks especially alongside common prescription medications.
Methodology
This is a news report summarizing expert commentary and clinical guidance from Stanford Medicine specialists, not a primary research study. It draws on clinical experience, national survey data (NSDUH 2023), and expert opinion rather than a new randomized controlled trial. Source credibility is high given Stanford Medicine affiliation, but the article reflects expert consensus and observational trends rather than experimental evidence.
Study Limitations
The article is based on expert opinion and clinical observation rather than a new peer-reviewed study, limiting direct evidence grading. Federal illegality has restricted large-scale longitudinal research on cannabis in older adults, meaning many risk estimates remain preliminary. Readers should consult primary clinical literature and discuss individual risk profiles with a healthcare provider before drawing personal conclusions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.